» Articles » PMID: 34276567

Coronavirus Disease 2019 and the Thyroid - Progress and Perspectives

Overview
Specialty Endocrinology
Date 2021 Jul 19
PMID 34276567
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

SARS-CoV-2 infection (COVID-19) is currently a tremendous global health problem. COVID-19 causes considerable damage to a wide range of vital organs most prominently the respiratory system. Recently, clinical evidence for thyroidal insults during and after COVID-19 has been accumulated. As of today, almost all non-neoplastic thyroid diseases, i.e., Graves' disease, Hashimoto's thyroiditis, subacute, painless and postpartum thyroiditis, have been reported as a complication of COVID-19, and causality by the virus has been strongly implicated in all of them. Similar thyroid problems have been reported in the past with the SARS-CoV outbreak in 2002. In this review, we briefly look back at the reported evidence of alteration in thyroid functionality and thyroid diseases associated with SARS-CoV and then proceed to examine the issue with COVID-19 in detail, which is then followed by an in-depth discussion regarding a pathogenetic link between Coronavirus infection and thyroid disease.

Citing Articles

Thyroid function during COVID-19 and post-COVID complications in adults: a systematic review.

Panesar A, Gharanei P, Khovanova N, Young L, Grammatopoulos D Front Endocrinol (Lausanne). 2025; 15:1477389.

PMID: 39967901 PMC: 11832367. DOI: 10.3389/fendo.2024.1477389.


Reversible central adrenal insufficiency in survivors of COVID-19: results from a 24-month longitudinal study.

Sahoo S, Menon J, Tripathy N, Nayak M, Yadav S Endocr Connect. 2024; 13(9).

PMID: 39045873 PMC: 11378128. DOI: 10.1530/EC-24-0086.


Hypocortisolemic ASIA: a vaccine- and chronic infection-induced syndrome behind the origin of long COVID and myalgic encephalomyelitis.

Ruiz-Pablos M, Paiva B, Zabaleta A Front Immunol. 2024; 15:1422940.

PMID: 39044822 PMC: 11263040. DOI: 10.3389/fimmu.2024.1422940.


The impact of environmental factors and contaminants on thyroid function and disease from fetal to adult life: current evidence and future directions.

Street M, Shulhai A, Petraroli M, Patianna V, Donini V, Giudice A Front Endocrinol (Lausanne). 2024; 15:1429884.

PMID: 38962683 PMC: 11219579. DOI: 10.3389/fendo.2024.1429884.


Inflammatory and Autoimmune Aspects of Multisystem Inflammatory Syndrome in Children (MIS-C): A Prospective Cohort Study.

Lawrence D, Jadhav A, Mondal T, Carson K, Lee W, Hogan A Viruses. 2024; 16(6).

PMID: 38932242 PMC: 11209514. DOI: 10.3390/v16060950.


References
1.
Ippolito S, Dentali F, Tanda M . SARS-CoV-2: a potential trigger for subacute thyroiditis? Insights from a case report. J Endocrinol Invest. 2020; 43(8):1171-1172. PMC: 7266411. DOI: 10.1007/s40618-020-01312-7. View

2.
Martin A, Davies T . T cells and human autoimmune thyroid disease: emerging data show lack of need to invoke suppressor T cell problems. Thyroid. 1992; 2(3):247-61. DOI: 10.1089/thy.1992.2.247. View

3.
Marshall M . COVID's toll on smell and taste: what scientists do and don't know. Nature. 2021; 589(7842):342-343. DOI: 10.1038/d41586-021-00055-6. View

4.
Tozzoli R, Barzilai O, Ram M, Villalta D, Bizzaro N, Sherer Y . Infections and autoimmune thyroid diseases: parallel detection of antibodies against pathogens with proteomic technology. Autoimmun Rev. 2008; 8(2):112-5. DOI: 10.1016/j.autrev.2008.07.013. View

5.
Ding Y, He L, Zhang Q, Huang Z, Che X, Hou J . Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol. 2004; 203(2):622-30. PMC: 7167761. DOI: 10.1002/path.1560. View